Pharmacokinetic Evaluation of Thrice-Weekly Ertapenem Dosing in Hemodialysis Patients Save

Date Added
June 7th, 2017
PRO Number
Pro00059031
Researcher
P. brandon Bookstaver
Keywords
Drug Studies, Infectious Diseases, Kidney
Summary

The regular use of ertapenem in hemodialysis (HD) patients warrants further exploration of optimal dosing of the drug, especially those which may minimize toxicity and improve adherence. This is a prospective study designed to characterize the drug concentration profile of an alternate dosing regimen (ertapenem 1 gram given three times weekly) in non-infected HD patients. The ultimate aim is to determine if ertapenem given three times weekly achieves adequate dosing targets to treat established infections and identify an optimal dosing scheme for ertapenem among patients on HD.

Institution
Palmetto
Recruitment Contact
Rachel Foster
(803) 434-2925
fosterr8@sccp.sc.edu

Change_preferences

-- OR --

Create_login